Carlotta Crisciotti

Dr. Carlotta Crisciotti

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SMStiliano Maimaris
Stiliano Maimaris
CSChiara Scarcella
Chiara Scarcella
GMGiusi Aurora Memoli
Giusi Aurora Memoli
CCCarlotta Crisciotti
Carlotta Crisciotti
ASAnnalisa Shiepatti
Annalisa Shiepatti
FBFederico Biagi
Federico Biagi
Non-coeliac wheat sensitivity (NCWS) is characterised by gastrointestinal and extra-intestinal symptoms following gluten/wheat ingestion in individuals without coeliac disease or wheat allergy but remains controversial due to symptom overlap with irritable bowel syndrome (IBS). This narrative review aims to provide a comprehensive, critical analysis of NCWS as a clinical and biological entity, examining the evidence for its distinction from related disorders. While self-reported rates are high (often >10%) in the general population, rigorous double-blind, placebo-controlled challenge (DBPCC) studies confirm the diagnosis in only a minority of cases (typically <30%). The clinical presentation is heterogeneous, combining IBS-like symptoms with systemic complaints such as “brain fog,” headaches, and fatigue. The pathophysiology is distinct from coeliac disease, involving innate immune activation, altered intestinal barrier function, and gut dysbiosis. Non-gluten wheat components, particularly fructans and amylase-trypsin inhibitors, are implicated as potential triggers. Diagnosis is challenging, requiring the exclusion of other disorders and adherence to complex dietary challenge protocols such as the Salerno Experts’ Criteria, which are impractical for routine clinical use. The search for validated biomarkers is a key research area and investigated candidates include serological markers such as IgG anti-gliadin antibodies, inflammatory markers such as faecal calprotectin, and proteins related to intestinal permeability such as zonulin, but results have been conflicting and require further validation. Management primarily involves elimination of wheat and gluten from the diet, although a low-FODMAP diet has also proven effective as an adjunctive treatment. In conclusion, NCWS is a clinical entity whose study and management are critically hampered by the absence of validated diagnostic criteria and biomarkers. Progress requires methodologically rigorous DBPCC trials to elucidate its mechanisms and develop reliable diagnostic tools.

Verified
Journal Article
Open access
PDF file
AMAurelio Mauro
Aurelio Mauro
CCCarlotta Crisciotti
Carlotta Crisciotti
GMGiulio Massetti
Giulio Massetti
DADaniele Alfieri
Daniele Alfieri
SMStefano Mazza
Stefano Mazza
AAAndrea Anderloni
Andrea Anderloni
Therapeutic endoscopic ultrasound (t-EUS) has transformed the management of biliopancreatic diseases by enabling minimally invasive access and intervention through the gastrointestinal wall. This narrative review summarizes current indications and evolving roles of t-EUS in benign and malignant biliary disease, with a focus on the different modalities of transmural drainage, EUS-guided gastroenterostomy (EUS-GE), and EUS-guided radiofrequency ablation (EUS-RFA). In benign settings, EUS-gallbladder drainage (EUS-GBD) has emerged as a minimally invasive alternative to percutaneous cholecystostomy for high-risk patients with acute cholecystitis, offering internal drainage with fewer tube-related adverse events. In malignant biliary obstruction, transmural drainages are consolidated alternatives of endoscopic retrograde cholangiopancreatography (ERCP) as first-line or rescue strategies, providing durable internal biliary drainage, avoiding post-ERCP pancreatitis without deteriorating quality of life. In surgically altered anatomy, t-EUS overcomes the limitations of enteroscopy-assisted ERCP by creating direct access routes to the biliary tree or pancreatic duct. EUS-guided pancreatic duct drainage offers a rescue or primary approach in benign strictures, anastomotic stenosis, and disconnected duct syndrome. EUS-GE has rapidly become a preferred modality for palliation of gastric outlet obstruction in pancreatic cancer, while EUS-RFA provides a platform for locoregional therapy in selected cases of pancreatic neuroendocrine tumors, adenocarcinoma, and pancreatic cystic neoplasms. Collectively, these applications position t-EUS as a central tool in the multidisciplinary management of complex biliopancreatic disease, with ongoing innovations expected to further expand its indications and safety and to refine patient selection and training pathways.

1 January 2025 in Case Reports in Medicine
Verified
Journal Article
Open access
CCCarlotta Crisciotti
Carlotta Crisciotti
AMAlessandra Marchese
Alessandra Marchese
PCPasquale De Cata
Pasquale De Cata
KVKaterina Vjero
Katerina Vjero
CVClaudia Vattiato
Claudia Vattiato
GAGiovanni Arpa
Giovanni Arpa
Background: Cronkhite–Canada syndrome (CCS) is a rare, nonhereditary gastrointestinal polyposis characterized by diffuse polyps, hyperpigmentation, onychodystrophy, and alopecia. Hypothyroidism has been infrequently reported in association with CCS. Case Presentation: A Caucasian male in his late 70s presented with dysgeusia, asthenia, and significant weight loss, initially diagnosed with Crohn’s disease. Physical examination showed onychodystrophy, hyperpigmentation, and leg edema. Laboratory tests revealed severe hypothyroidism, hypoalbuminemia, and elevated serum IgG‐4 levels. Upper and lower endoscopies showed diffuse gastric and colonic polyposis with chronic inflammation, eosinophilic infiltration, and hyperplastic changes. Diagnosis of CCS was confirmed. Treatment included corticosteroids and thyroid hormone replacement. Conclusion: This case highlights CCS diagnostic challenges, particularly when misdiagnosed as inflammatory bowel disease. The coexistence of hypothyroidism and elevated serum IgG‐4 levels suggests a possible autoimmune component. Early recognition of this rare syndrome is essential for appropriate management.